The benefits of exercise are limited, disappear if discontinued, and should be an adjunct to talk or drug therapy.

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

The Institute for the Advancement of Food & Nutrition Science publishes a list of general principles it hopes will inform any ...

The FDA released a draft guidance document that provides a regulatory framework for sponsors to utilize minimal residual ...

Jay Bhattacharya, the N.I.H. director, says authorities broke the public’s trust in the Covid era. Now it’s up to outsiders ...

Verifying an extensible processor is more than a one-step process, especially when software compatibility is important.

AI is rapidly transforming hospital medicine by supporting clinical workflows, enhancing decision-making, and reducing ...

Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

As 2026 dawns, look for HHS Secretary Robert F. Kennedy Jr. to ramp up his assault on vaccines using policy-based evidence making and altering Vaccine Court standards.